Clinical Trial Update: Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating intralesional levofloxacin for the management of cutaneous leishmaniasis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Hayder Adnan Fawzi | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: RECRUITING